SIAG
GSK icon

Signet Investment Advisory Group’s GSK GSK Stock Holding History

Signet Investment Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,360
Closed -$155K – 124
2020
Q4 		$155K Buy
+3,360
New +$154K 0.12% 79
2019
Q4 		$272K Hold
4,640
– – 0.25% 65
2019
Q3 		$248K Hold
4,640
– – 0.25% 65
2019
Q2 		$232K Buy
4,640
+360
+8% +$18.1K 0.24% 66
2019
Q1 		$223K Buy
+4,280
New +$214K 0.24% 65

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Signet Investment Advisory Group's GSK Position: Q1 2021 in Review

Signet Investment Advisory Group sold out of GSK (GSK) in Q1 2021, closing a stake of 3,360 shares — an estimated $155K sold.

Signet Investment Advisory Group first reported a position in GSK in Q1 2019 and held it in 5 quarters. The position peaked at $272K in Q4 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Signet Investment Advisory Group reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Signet Investment Advisory Group sold 3,360 GSK shares in Q1 2021, an estimated $155K.
  • Signet Investment Advisory Group first reported a position in GSK in Q1 2019 and held it in 5 quarters.
  • Signet Investment Advisory Group's GSK position peaked at $272K in Q4 2019.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Signet Investment Advisory Group's 13F filing for Q1 2021, filed 11 May 2021.